Mitiglinide
- Generic Name
- Mitiglinide
- Drug Type
- Small Molecule
- Chemical Formula
- C19H25NO3
- CAS Number
- 145375-43-5
- Unique Ingredient Identifier
- D86I0XLB13
- Background
Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.
- Indication
用于改善2型糖尿病患者餐后高血糖(仅限用于经饮食、运动疗法不能有效控制血糖的患者或在饮食、运动疗法的基础上加用α-葡萄糖苷酶抑制剂后仍不能有效控制血糖的患者)。
- Associated Conditions
- Blood Glucose, Postprandial, Type 2 Diabetes Mellitus
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2008-10-21
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 291
- Registration Number
- NCT00461617
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath